24.6 C
New York
HomeLifestyleHealth & FitnessCramer's Investing Club: Buy Eli Lilly's drop on drug delay news because...

Cramer’s Investing Club: Buy Eli Lilly’s drop on drug delay news because it won’t matter long term


We see the pushback of donanemab’s accelerated approval submission as just a speed bump.

Stay Connected
16,985FansLike
52,146FollowersFollow
2,458FollowersFollow
spot_img
Must Read
You might also like

LEAVE A REPLY

Please enter your comment!
Please enter your name here